Introduction {#s1}
============

The basic helix loop helix (bHLH) transcription factors are critical regulators of early development ([@b37]; [@b3]; [@b10]), with roles in regulating organogenesis and neurosensory development ([@b44]; [@b32]; [@b55]; [@b9]). Members of the Hairy-Enhancer of Split (HES) subfamily act primarily in response to Notch signaling ([@b12]; [@b23]), and are known for roles in neural ([@b24]; [@b31]; [@b50]) and cardiovascular ([@b13]; [@b52]; [@b51]) development. In humans, mutations in the HES genes are often associated with neuroblastoma ([@b1]; [@b48]), neuroendocrine tumors of the breast, lung, and prostate ([@b19]; [@b36]; [@b40]), and early developmental disorders ([@b46]; [@b47]). While members of the bHLH superfamily are also needed post-embryonically for metamorphosis ([@b33]; [@b43]; [@b4]), sexual development and gamete formation ([@b49]; [@b2]; [@b35]), and maintaining homeostasis ([@b56]; [@b30]; [@b34]), little is known about the post-embryonic, non-developmental roles of the HES family proteins.

Ovulation in *Caenorhabditis elegans* is a tightly regulated process that demonstrates how cells and tissues must coordinate major signaling events to function. Critical to the ovulation cycle are a series of communication events between the proximal oocyte and sperm, and between the gametes and the surrounding sheath cells of the somatic gonad ([@b18]; see [Fig. 1](#f01){ref-type="fig"}). After receiving molecular signals from the sperm, the proximal oocyte undergoes maturation and sends its own signal to the gonadal sheath cells to amplify contractions that were initiated by the sperm-derived signals ([@b16]; [@b14]). These oocyte-derived signals, which include the *C. elegans* epidermal growth factor homolog, LIN-3, also activate the dilation of the distal spermatheca valve. Ovulation occurs when the oocyte is propelled into the spermatheca. Sheath cell contractions, dilation of the distal spermatheca valve, and dilation of the spermatheca-uterine (SP-UT) valve after fertilization all require intracellular calcium release that is induced by LIN-3 dependent, inositol triphosphate (IP~3~) signaling in the spermatheca and sheath cells ([@b8]; [@b7]; [@b54]). Here we show that the HES-like protein HLH-29 controls spermatheca entry and exit by altering the expression of genes required for IP~3~ signaling, thereby providing one of the first links between a HES protein and the coordination of a rhythmic post-embryonic biological process.

![HLH-29 is expressed in the adult spermatheca during ovulation.\
**(A)** Ovulation in wild-type animals is stimulated when major sperm (MSP) proteins bind to receptors on the proximal oocyte and the proximal gonad to stimulate meiotic maturation and gonad contractions, respectively. The oocyte then secretes LIN-3 protein, which binds to the receptor protein LET-23 and amplifies the gonad contractions. LET-23 activation also triggers the dilation of the distal spermatheca valve. The oocyte is propelled into the spermatheca, where it is fertilized and subsequently expelled through the SP-UT valve into the uterus. **(B--G)** *hlh-29*::GFP expression in the spermatheca of animals bearing an integrated transcriptional reporter construct. Corresponding DIC images are shown on the left of each epifluorescence micrograph. (B,C) Lateral view, L2/L3 stage. Cells of the somatic primordium are circled. (D,E) Dorsal view, early L4 stage. Anterior spermatheca is circled; arrow indicates uterus and vulval lumen. (F,G) Lateral view, adult stage. Posterior spermatheca is circled; arrow indicates vulva muscles.](bio-01-03-261-f01){#f01}

Materials and Methods {#s2}
=====================

Nematode handling and strains {#s2a}
-----------------------------

The following strains were used: N2 Bristol wild-type ([@b5]); TM284, *hlh-29(tm284)*; SL232, *unc-51*(e1189) *fog-2(q71)*/*fog-2*(q71) *rol-9(sc148)*; PS2286, *unc-38(x20) lfe-2(sy326)*; PS3656, *ipp-5(sy605)*. Transgenic lines carrying an integrated *hlh-29*::GFP transgene were previously described ([@b39]). Culture growth and synchronization by alkaline hypochlorite treatment were as previously described ([@b29]).

Brood Size and Epistasis Analysis {#s2b}
---------------------------------

Animals were raised for at least two generations at 22°C prior to the start of assays, and were fed bacteria producing dsRNA for either the control gene *unc-55* or for the test genes ([@b25]). It should be noted that because *hlh-28* and *hlh-29* produce identical mRNAs, RNAi against *hlh-29* mRNA also knocks down *hlh-28* mRNA. Therefore, the RNAi effects described here may be the result of knockdown of both *hlh-28* and *hlh-29* and we will refer to this treatment as *hlh-29/hlh-28* RNAi. For brood size assays and for ovulation assays with *fog-2* animals, L4 stage hermaphrodites were serially transferred to fresh plates every 24 hours throughout their egg laying period. For epistasis analysis, L1 stage animals were fed control bacteria for 56 hours at 22.5°C and then moved, individually, to 35 mm NGM plates seeded with bacteria producing the appropriate dsRNA. Eggs and oocytes were counted twice: when the adult hermaphrodite was first removed from the plates, and again 24 hours later. The data are presented as the number of viable progeny (brood size), and oocyte percentage (number oocytes/(number oocytes + viable progeny). Inviable and abnormally shaped eggs were eliminated because we could not consistently differentiate between fragmented eggs and fragmented oocytes. Finally, the *hlh-29(tm284)* animals used for these assays were homozygous for the tm284 allele.

Time-lapse Microscopy {#s2c}
---------------------

Animals were anesthetized with 0.1% levamisole ([@b15]), mounted on 2.0% agarose pads and imaged using a 60X oil-immersion objective with a Nikon Eclipse 90i microscope equipped with a Nikon Coolsnap CCD camera. Images were captured at 3 second intervals over a 115 minute period using NIS-elements, version 3.2 software (Nikon). Audio video interleave (AVI) files were generated by NIS-elements and compressed using H.264, then exported as moving picture experts group, standard 4 (MPEG-4) movies using Xilisoft Video Converter Ultimate, Version 6.0.7. Because ovulation occurred sporadically in *hlh-29(tm284)* homozygous animals due in part to variable defects in the gonad morphology, we used *hlh-29/hlh-28* RNAi treated *hlh-29(tm284)* heterozygotes to capture ovulation by time lapse microscopy.

Gene Expression Analysis {#s2d}
------------------------

Gene expression analysis, including total RNA extraction, cDNA synthesis, and real-time PCR were carried out as previously described ([@b11]). Total RNA was extracted from late L4 or early adult stage populations, and cDNA synthesis reactions were performed in 50 µL reaction volumes containing 10.0 µg of total RNA. Real time PCR assays were performed with Taqman Gene Expression Assays (Applied Biosystems) specific for each putative target (supplementary material Table S1), using relative quantitation with normalization against the endogenous control gene *pmp-3* ([@b21]).

Egg-laying Measurements {#s2e}
-----------------------

Egg-laying in the presence of food was assayed using synchronized cultures that were fed for 72 hours after hatching at 22°C. Two hermaphrodites were placed onto seeded, 35 mm NGM plates and incubated at 22°C. After two hours, the number of eggs and unfertilized oocytes were counted. Animals that did not produce progeny or who ruptured through vulva (exp) during the assay were excluded. For this assay N = 30; each experiment was repeated in triplicate.

For egg laying assays in the absence of food, each culture of L1 stage animals was fed bacteria producing the appropriate dsRNA for 72 hours. Animals were then picked onto an unseeded NGM plate and allowed to crawl around for 30 minutes so that all bacteria could be removed from their bodies. Hermaphrodites were then placed individually into each well of a 48-well tissue culture plate containing 25 µL of M9 buffer, and incubated at 22°C for 1 hour. Animals that ruptured through the vulva while in buffer or that displayed anatomical defects were excluded from the assay. For this assay, N = 288; each experiment was repeated 5 times.

Results and Discussion {#s3}
======================

HLH-29 is expressed in the spermatheca and plays a role in egg-laying {#s3a}
---------------------------------------------------------------------

Previously, we reported that RNAi knockdown of *hlh-29* and the duplicate gene *hlh-28* results in the exploded through vulva (exp), protruding vulva (pvl), and accumulated endomitotic oocytes (emo) phenotypes ([@b39]). Additionally, a fraction of RNAi animals failed to form a uterus, failed to develop one of the two gonad arms, or accumulated either unfertilized or emo oocytes in the uterus. These phenotypes are also evident in animals that carry null alleles of either *hlh-29* or *hlh-28*. Both *hlh-29* and *hlh-28* are expressed in all cells of the EMS lineage in early embryos ([@b6]; [@b42]). The post-embryonic expression pattern of *hlh-28* is unknown; however an *hlh-29*::GFP transcriptional reporter is expressed in cells of MS descendants that give rise to the adult spermatheca and vulva muscles ([@b39]). Together, these data suggest a pleiotropic role for HLH-29 and HLH-28 in reproduction. We sought to better understand the role of HLH-29 in reproduction and we reasoned that any functional differences between the identical proteins HLH-29 and HLH-28 would be due solely to differences in timing and location of expression. It should be noted, however, that because *hlh-29* and *hlh-28* are identical genes, with the exception of an additional exon in *hlh-28* that is believed to be removed via splicing ([@b39]), RNAi knockdown of *hlh-29* also results in knockdown of *hlh-28*. This raises the possibility that the RNAi phenotypes described below may be the result of reduction in the activities of both genes.

*hlh-29* is expressed in most cells of the spermatheca of L4 and adult animals, and in the vulva muscles, but not in the spermatheca or vulval precursor cells of younger animals ([Fig. 1](#f01){ref-type="fig"}). Unlike in wild-type animals, egg-laying rates in *hlh-29(tm284)* animals are not responsive to changes in food availability (supplementary material Fig. S1), and more interestingly, *hlh-29(tm284)* animals lay unfertilized oocytes throughout their egg-laying period. Most of these unfertilized oocytes were endomitotic, as indicated by disorganized and enlarged nuclei ([@b22]); however, *hlh-29(tm284)* animals also lay unfertilized oocytes that have distinct, normal-sized nuclei or that appear to lack a nucleus. To determine whether the unfertilized oocytes phenotype is solely from exhausting the supplies of active sperm or is also the result of defective ovulation cycles, we treated *fog-2(q71)* animals with RNAi against *hlh-29/hlh-28*. *fog-2* animals do not produce sperm and can be used to identify genes that function during ovulation ([@b14]). We found that *fog-2(q71)* animals eating either OP50 or bacteria producing control RNAi laid an average of 2.9 oocytes/24 hours at 25°C (SEM  = 0.449, n = 156), while *fog-2(q71)*; *hlh-29/hlh-28*(RNAi) animals laid an average of 28.73 oocytes/24 hours (SEM  = 1.345, n = 190, p-value  = 4.27e^−19^). While this result does not rule out the possibility that *hlh-29* affects sperm viability and function, it does support a sperm-independent role for *hlh-29* in regulating reproduction.

Ovulation is defective in *hlh-29* animals {#s3b}
------------------------------------------

In wild-type animals, each gonad arm ovulates one mature oocyte on average of every 23 minutes. In the oocyte, the events leading up to ovulation include distal nuclear migration, breakdown of the nuclear envelope, and cortical rearrangement. Ovulation itself, the propulsion of the mature oocyte into the spermatheca, requires intense rhythmic contractions of the surrounding gonad sheath cells, followed by dilation or extension of the distal spermatheca valve. In wild-type animals, the ovulated oocyte is fertilized almost immediately, and within five minutes of ovulation, the fertilized egg emerges through the SP-UT valve into the uterus ([@b38]).

The morphology of the gonad arms is affected in animals lacking HLH-29 ([@b39]), making it difficult to analyze ovulation in *hlh-29(tm284)* homozygous animals. HLH-29′s effect on gonad morphology appears to be dose and developmental stage dependent, and we were able to separate this phenotype from the ovulation phenotype by subjecting L3 stage heterozygous *hlh-29(tm284)* animals, to *hlh-29/hlh-28* RNAi. The ovulation defects were the same in N2 and in *hlh-29(tm284)* heterozygous animals treated with *hlh-29/hlh-28* RNAi, and also in *hlh-29(tm284)* homozygotes. These defects ranged from complete failure of the oocyte to enter the spermatheca to complete failure of the fertilized egg to exit the spermatheca. We found, however, that defective ovulation occurred more frequently in RNAi treated *hlh-29(tm284)* heterozygotes than in N2 animals. Therefore, we used *hlh-29/hlh-28* RNAi treat *hlh-29(tm284)* heterozygotes, referred to henceforth as *hlh-29(tm284)/+ hlh-29/hlh-28*(RNAi) animals, to capture the ovulation defects by time-lapse microscopy.

Distal nuclear migration, breakdown of the nuclear envelope, and cortical rearrangement appeared to occur normally in *hlh-29(tm284)/+ hlh-29/hlh-28*(RNAi) animals, suggesting that HLH-29 is not required for oocyte maturation. This result was unexpected in light of the *fog-2; hlh-29/hlh-28* (RNAi) results described above. Genes previously shown to influence ovulation in *fog-2* animals are believed to negatively regulate meiotic maturation. RNAi knockdown of those genes normally increases maturation rates in unmated *fog-2* females, though not to the same rates as those seen in hermaphrodites or in mated *fog-2* females ([@b14]). It is possible that HLH-29 and HLH-28 function in different tissues to regulate the expression of two separate sets of genes that are required to separate meiotic maturation and the initiation of ovulation from physical movement through the spermatheca. This possibility would explain why ovulation increases in *fog-2; hlh-29/hlh-28* (RNAi) animals and also may explain why *hlh-29/hlh-28* RNAi rescues the brood size phenotypes of *hlh-29(tm284)* animals (see below).

Loss of HLH-29 did not appear to affect gonadal sheath contractions; however, the ability of oocytes and fertilized eggs to enter and exit the spermatheca, respectively, was affected (supplementary material Movies 1--3). This ovulation defect was highly variable and occurred randomly in either gonad arm. We compared ovulation events over a 90 minute period in wild-type and in *hlh-29(tm284)/+ hlh-29/hlh-28* (RNAi) animals (supplementary material Table S2), and defined a successful event as entry into the spermatheca followed by unassisted exit out of the spermatheca within eight minutes. This eight minute fertilization window is significantly longer than the previously published wild-type fertilization window of two minutes ([@b38]), and may have resulted in an underestimation of the number of abnormal ovulation events. We observed a total of 14 ovulation events in a single gonad arm of 4 different wild-type animals; all but one of these events occurred normally, at an average frequency of one every 21.5 minutes. Similarly, N2 animals treated with control RNAi had normal ovulation events that occurred at an average frequency of one every 28 minutes (data not shown).

We observed a total of 46 ovulation events in a single gonad arm of 21 different *hlh-29(tm284)/+ hlh-29/hlh-28* (RNAi) animals, 24 of which occurred normally (supplementary material Table S2). The average frequency of attempted/successful ovulation events in these animals was one every 41 minutes. This average does not include the ovulation attempts made by gonad arms that became blocked within the 90 minute observation period. Failure of either the distal spermatheca valve or the SP-UT valve to function properly resulted in fragmented oocytes and embryos which accumulated in the gonad arms and uterus, or in occupancy of the spermatheca by multiple oocytes ([Fig. 2A--I](#f02){ref-type="fig"}), some of which eventually become emo. In 11 of 21 events, abnormal ovulations were caused by failure of the distal spermatheca valve to function properly. Oocytes failed to enter the spermatheca (8/11), were fragmented upon entry because the valve closed prematurely (2/11), or fell back into the gonad arm (1/11) because the valve failed to close completely (supplementary material Fig. S2A--C). In 7 of 21 events, abnormal ovulations were caused by failure of the SP-UT valve to function properly. The most infrequent failures occurred when the SP-UT valve failed to open at all, resulting in blockage of the spermatheca (1/7) or of the gonad arm (1/7) by a fertilized egg. More often, the fertilized egg exited the spermatheca either unassisted after a prolonged occupancy (1/7), or as a result of entry into the spermatheca by a second oocyte (4/7). The fate of the second oocyte included successfully fertilized and ovulated (1), fragmented exit into the uterus (1/4), forced exit into the gonad arm (1/4), and rapid exit into the uterus without fertilization (1/4). Taken together, defective ovulation in *hlh-29(tm284)/+ hlh-29/hlh-28*(RNAi) animals appears to be the result of mechanical failure of both of the spermatheca valves.

![Time lapse observations of ovulation.\
**(A--I)** Representative abnormal ovulation in an *hlh-29(tm284)/+ hlh-29/hlh-28*(RNAi) animal. The spermatheca is outlined in black, the uterus, with developing embryos, is indicated by UT, and the first four oocytes in the gonad arm are numbered. Oocyte 1 enters and exits the spermatheca successfully, but oocyte 2 is not able to exit until oocyte 3 is ovulated. All subsequent ovulations are blocked when oocyte 3 is fragmented (indicated by 3 and 3′) while exiting backwards through the distal valve. **(J--R)** Representative ovulation in an animal carrying the integrated *hlh-29*::GFP transgene. Expression in the spermatheca is concentrated in the distal (white arrow) and the SP-UT valves (arrowhead). The ovulating oocyte (fertilized embryo in P & R) is outlined in red.](bio-01-03-261-f02){#f02}

Consistent with this mechanical failure, *hlh-29* activity localized to both the distal and proximal valves of the spermatheca ([Fig. 2J-R](#f02){ref-type="fig"}; supplementary material Movie 4). Together, these results suggest that HLH-29 is required to allow successful entry into and exit from the spermatheca.

HLH-29 acts as a positive and a negative regulator of genes expressed in the adult spermatheca {#s3c}
----------------------------------------------------------------------------------------------

We tested the effect of loss of *hlh-29* activity on genes whose expression overlapped with *hlh-29* in the spermatheca and that were previously shown to affect ovulation. We found that loss of HLH-29 reduced the activity of *ppk-1* and increased the activities of *plc-1* and *ipp-5* ([Fig. 3A](#f03){ref-type="fig"}), three genes required for IP~3~ signaling. Loss of HLH-29 also caused a 1.3 fold increase in *lfe-2* activity, though this change was not found to be statistically significant.

![HLH-29 and the IP~3~ signaling.\
**(A)** Transcriptional activity of genes in the IP~3~ signaling transduction pathway are affected in *hlh-29(tm284)* animals. Bars represent the relative fold-change in mRNA levels as detected by RT-qPCR when compared to expression in wild-type animals, error bars represent standard error of the mean. Fold expression range considered to be the same as wild-type expression is indicated by light gray shading, centered around the value of 1.0. P values are indicated to the right of each bar. **(B)** Components of the LIN-3/LET-23 activated IP~3~ signaling transduction pathway are transcriptionally regulated by HLH-29.](bio-01-03-261-f03){#f03}

We looked for genetic interactions between *hlh-29* and *ppk-1*, *ipp-5*, and *lfe-2* using measurements of brood size and percentage of unfertilized oocytes (see methods and materials). *ppk-1* encodes a kinase that converts phosphatidylinositol-4-phosphate (PIP) into phosatidylinositol 4, 5-bisphosphate (PIP~2~), which is subsequently hydrolyzed by phospholipase C into the second messengers diacylglycerol (DAG) and inositol 1,4,5-triphosphate (IP~3~) ([Fig. 3B](#f03){ref-type="fig"}). Loss of PPK-1 causes the accumulation of oocytes in the gonad arms due, in part, to the absence of gonadal sheath contractions during ovulation ([@b53]). Feeding newly hatched N2 or homozygous *hlh-29(tm284)* animals bacteria producing *ppk-1*dsRNA resulted in 100% sterility (not shown). We found that N2 and *hlh-29(tm284)* animals that received *ppk-1* RNAi after L3 stage produced almost as many viable progeny as those that were subjected to control RNAi ([Fig. 3B](#f03){ref-type="fig"}) during the same time period, and so we used these animals for the epistasis assays. Wild-type animals laid a small percentage of unfertilized oocytes at the end of their egg-laying period ([Fig. 4A](#f04){ref-type="fig"}), but this percentage was reduced in *ppk-1* (RNAi) animals. *hlh-29(tm284)* animals laid unfertilized oocytes throughout their egg-laying period and laid a significantly higher percentage than wild-type animals. This phenotype was suppressed by *ppk-1* RNAi ([Fig. 4A](#f04){ref-type="fig"}), indicating that *ppk-1* is epistatic to *hlh-29*, and further supporting our molecular finding that *hlh-29* acts upstream of *ppk-1*.

![Genetic interactions between hlh-29 and selected IP3 signaling genes.\
**(A)** Genetic interactions between *hlh-29* and *ppk-1*. **(B)** Genetic interactions between *hlh-29* and *lfe-2*. **(C)** Genetic interactions between *hlh-29* and *ipp-5*. Dark bars represent the percentage of oocytes (unfertilized) laid on plates out of the total number of viable, fertilized eggs and unfertilized oocytes. Not included in these numbers were irregularly shaped, inviable eggs and egg fragments. White bars represent the total brood size, or absolute number of viable, fertilized eggs. Data represent the mean of three experiments, error bars represent standard error of the mean, *N* was equal to ten, and significance was determined using single factor ANOVA. All animals were compared to N2 eating control RNAi, except in C where *ipp-5* animals were compared to *hlh-29(tm284)* animals under the same RNAi conditions. \* P-value \<0.05; \*\* P-value \<0.005; \*\*\* P-value \<0.0005.](bio-01-03-261-f04){#f04}

The enzymes IP~3~ kinase, encoded by *lfe-2*, and inositol polyphosphate 5-phosphatase, encoded by *ipp-5*, function to reduce the intracellular levels of IP~3~ ([@b8]; [@b7]). Loss of either IPP-5 or LFE-2 effectively increases IP~3~ levels, but results in only moderate ovulation defects. *ipp-5* animals produce fewer progeny than wild-type animals and lay unfertilized oocytes because of a hyperactive distal spermatheca valve ([@b7]). *lfe-2* animals also have small brood sizes, but no other ovulation defects are evident ([@b8]). Interestingly, animals that carry loss-of-function alleles in both *ipp-5* and *lfe-2*, and animals that over-express *lfe-2* are sterile. In the latter case, sterility is caused by failure of the spermatheca-uterine valve to open ([@b8]), a phenotype very similar to the ovulation defect of *hlh-29(tm284)/+ hlh-29/hlh-28*(RNAi) animals and in support of slightly increased *lfe-2* activity in *hlh-29(tm284)* animals. In our genetic interaction studies, *lfe-2(sy36)*; *hlh-29/hlh-28*(RNAi) animals and *ipp-5(sy605)*; *hlh-29/hlh-28*(RNAi) animals laid a significantly higher percentage of unfertilized oocytes than either wild-type or single mutant animals ([Fig. 3B,C](#f03){ref-type="fig"}). Additionally, brood sizes were significantly reduced in *hlh-29(tm284)*, *ipp-5(sy605)*, and *lfe-2(sy36)* animals when compared to wild-type, and were reduced further in *ipp-5(sy605)*; *hlh-29/hlh-28*(RNAi) and *lfe-2(sy36)*;*hlh-29/hlh-28*(RNAi) animals. These results show genetic interactions between *hlh-29* and *ipp-5* and between *hlh-29* and *lfe-2*, and we suggest that they are representative of the phenotypes that would be expected in either *lfe-2*(gain-of-function); *ipp-5*(loss-of-function) or *lfe-2*(loss-of-function); *ipp-5*(gain-of-function) animals.

The percentage of unfertilized oocytes in *hlh-29(tm284)* animals does not change significantly upon treatment with *hlh-29/hlh-28* RNAi, suggesting that HLH-29 and HLH-28 do not function redundantly to control ovulation ([Fig. 4A](#f04){ref-type="fig"}). Interestingly, the brood size data contradicts this interpretation, as *hlh-29(tm284)* animals show significantly larger brood sizes after treatment with *hlh-29/hlh-28* RNAi. One possibility for this discrepancy would be that RNAi artificially induces egg-laying via a process that is independent of HLH-29 and HLH-28. We do not believe this explanation is plausible, however, because brood size was not increased in *hlh-29(tm284)* animals subjected to control RNAi when compared to those that were untreated with RNAi (compare [Fig. 4A to F](#f04){ref-type="fig"}ig. 4C). We suggest that this result and the *fog-2(q71)*; *hlh-29/hlh-28* (RNAi) results presented above are indicative of a separate function for HLH-28 in controlling ovulation events upstream of spermatheca entry and exit.

HLH-29 and HLH-28 affect the morphology of the gonad arm {#s3d}
--------------------------------------------------------

As mentioned above, animals that are homozygous for *hlh-29(tm284)* show variably abnormal morphological defects of the somatic gonad which became more pronounced when animals were cultured at higher temperatures. Because our data showed that *hlh-29/hlh-28* RNAi can rescue the brood size phenotype of *hlh-29(tm284)* animals, we expected that the gonad morphology defects would also be rescued. Surprisingly, gonad defects were more pronounced in *hlh-29/hlh-28* RNAi treated *hlh-29(tm284)* animals than in untreated animals, though the phenotype was still variably expressed and incompletely penetrant. Supplementary material Fig. S2D,E shows an animal representative of the morphology defects seen in some *hlh-29(tm284) hlh-29/hlh-28(RNAi)* animals. To identify genes that may be targeted by either HLH-29 or HLH-28 during gonad development, and to determine if HLH-28 and HLH-29 may be jointly regulating expression of those genes, we compared the activities of the IP~3~ signaling genes and the activities of six other genes whose expression overlapped with *hlh-29* in at least two tissues and that were previously shown to affect reproduction (supplementary material Table S1A) in *hlh-29(tm284)* and *hlh-29(tm284)* animals treated with *hlh-29/hlh-28*(RNAi). The expression of five of these genes was affected in *hlh-29(tm284)* animals (supplementary material Table S1B). These genes and the proteins they encode are: *nhr-6*, a NR4A nuclear receptor protein required for spermatheca development ([@b20]); *emb-9*, a Type IV basement membrane collagen required for embryonic morphogenesis ([@b17]); *sca-1*, a calcium transporting ATPase that is predicted to interact with the IP~3~ receptor protein, ITR-1 ([@b41]); and two genes required for gonadal morphogenesis, *mig-6*, an extracellular matrix protein ([@b26]) and *pyp-1*, nucleosome remodeling factor ([@b27]). We found that the expression of *sca-1*, *nhr-6*, *emb-9*, and most of the IP~3~ signaling genes was similarly affected in RNAi treated animals; however, the expression of *pyp-1*, *mig-6*, and the IP~3~ signaling pathway gene *let-23*, was affected differently in RNAi treated *hlh-29(tm284)* animals (supplementary material Table S1C). Altogether, these results suggest that both HLH-28 and HLH-29 are required for normal development of the somatic gonad.

Conclusions {#s4}
===========

Our molecular and genetic data indicate that HLH-29 acts in both the distal spermatheca valve and the spermatheca-uterine valve to regulate ovulation by mediating IP~3~ signaling ([Fig. 3B](#f03){ref-type="fig"}). Previous studies have identified bHLH proteins as regulators of the IP~3~ receptor genes in mice ([@b28]) and in yeast ([@b45]); however, this is the first to show coordinated regulation of multiple genes within the IP~3~ signaling pathway. HLH-29 is a member of the *C. elegans* REF-1 family, functional homologs of HES proteins ([@b42]). Our results, then, are one of the first to demonstrate the involvement of a HES protein in the modification and regulation of an adult phenotype and a possible link between IP~3~ and Notch signaling in this organism. These results also underscore the importance of tight regulation of the IP~3~ signaling cascade, and demonstrate how IP~3~ signaling can be modulated at multiple inputs in the pathway. Previous results show that perturbing any of the genes in this pathway can have moderate to severe effects on ovulation. HLH-29 seems to act to increase the levels of IP~3~, either by activating the *ppk-1* gene, or by repressing *lfe-2* and *ipp-5*, two genes needed to reduce intracellular levels of IP~3~. Our gene expression data also suggest that HLH-29 represses the gene for phospholipase C ε, *plc-1*. This result contradicts our genetic data, which strongly correlate with ovulation phenotypes seen in *plc-1* loss of function mutants. One plausible explanation is that the expression levels reported here are indicative of HLH-29 dependent regulation of *plc-1* levels in cells outside of the spermatheca. Finally, our results indicate that HLH-29 regulates genes required for the development of the spermatheca and of the somatic gonad, and are particularly exciting in that they underscore the ability of HES proteins to regulate tissue morphology and organ development in larval and adult animals. This study did not directly address the possible roles of HLH-28 in reproduction; however, treating either *fog-2* animals or *hlh-29* animals with *hlh-29/hlh-28* RNAi increased the total number of ovulation events in both strains. These results suggest that HLH-28 may negatively regulate ovulation separately from HLH-29.
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======================
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